Blog
Is Guardant Health Stock a Buy?
Many cancer patients undergoing treatment have impaired immune systems, so it's not a big surprise that some of them stayed away from clinic settings during the spring, when cases of COVID-19 were
Is Canopy Growth Stock a Buy?
Canadian marijuana company Canopy Growth (NYSE: CGC) sells everything from raw cannabis flowers to THC-infused beverages and cannabidiol hand creams. With its diverse collection of brands, it's
The Best Pot Stock for the Next 10 Years
While Canada technically made medical cannabis legal in 2001, its federal courts didn't allow producers to market cannabis until 2016. Recreational cannabis, which included flowers, oils, plants,
Why I Think Bristol Myers Squibb Is Too Cheap to Miss
For investors in pharmaceutical companies, few things are more concerning than a loss of market share, particularly if it's because of the patent expiration of a blockbuster drug. Bristol Myers
Quidel and OPKO Health Are Scoring With Coronavirus Testing in Sports. Is the Market Missing It?
After shutting down its season on March 11, the NBA resumed games four months later, isolated in a Walt Disney World complex. After that four-month experiment in sequestering teams, coaches, and
Why Are Pot Stocks Popping?
October has been a good month for the marijuana industry, with the Horizons Marijuana Life Sciences ETF up about 13% so far against the S&P 500's 4% climb. Many pot stocks, including Canopy Growth
Better Coronavirus Stock: AstraZeneca or Moderna?
Over the last few months, AstraZeneca (NYSE: AZN) and Moderna (NASDAQ: MRNA) have emerged as frontrunners in the race for a coronavirus vaccine. Both vaccine efforts are in the midst of the final
Got $3,000? 3 Edge Computing Stocks to Buy Right Now
With over a decade of rapid cloud expansion, the next wave of data center-powered computing is now under way: edge computing. Put simply, edge computing brings data out of a centralized cloud to a
26% of Americans Misunderstand Medicare -- and It Could Ruin Their Retirement
When you're saving for retirement, it's imperative to consider all costs you're likely to incur in your later years. Unfortunately, just over a quarter of Americans are laboring under a major
Why You Should Buy Starbucks Before the Earnings Release
After losing almost 40% of its price in the March crash, Starbucks (NASDAQ: SBUX) stock turned positive year to date just last week. Revenue is steadily improving, and the company beat on sales and
Where Will Anheuser-Busch InBev Be in 1 Year?
Anheuser-Busch InBev (NYSE: BUD), the world's largest brewer, has lost 40% of its stock value over the past 12 months as it struggled with sluggish sales of beer, high commodity costs, and
Aurora Cannabis: Buy the Dip?
Investing guru Warren Buffett once said, "We simply attempt to be fearful when others are greedy and to be greedy only when others are fearful." In the context of Aurora Cannabis' (NYSE: ACB) fall
Where Will Aurora Cannabis Be in 1 Year?
Canadian cannabis company Aurora Cannabis (NYSE: ACB) saw a bright future ahead when Canada legalized adult-use recreational marijuana in October 2018. But Aurora's acquisition spending spree, rapid
Got $5,000? Here Are 2 Dividend Growth Stocks to Buy and Hold for Decades
If you are in a financial position to invest $5,000 in new stocks today, you will find no shortage of exciting options. If you would like to balance the potential for solid returns with long-term
Why I'm Buying Shares of Ontrak and Unity Software
It's no secret that companies involved in cloud computing, virtual direct-to-consumer sales, artificial intelligence (AI), and augmented reality (AR) are onto something big. Two exciting stocks come
Could This Healthcare SaaS Stock Be the Next Veeva Systems?
It's no longer a secret that the software-as-a-service (SaaS) business model has huge advantages. It costs next to nothing to give a new customer access; upgrades are the norm; and wide moats form
3 Green Flags for Aurora Cannabis' Future
For investors in troubled Canadian marijuana cultivator Aurora Cannabis (NYSE: ACB), good news is in short supply. The company is nowhere near profitability, and its stock has been falling since
10 Reasons Bitcoin Is a Terrible Investment
It's been a challenging year for Wall Street. We've witnessed the quickest bear market decline of at least 30% in history, as well as the most ferocious comeback of all time, with the benchmark S&P
Netflix Versus Amazon Prime: The Race to 200 Million Subscribers
While many businesses struggle to survive the consequences of the COVID-19 pandemic, Netflix (NASDAQ: NFLX) and Amazon (NASDAQ: AMZN) are thriving. The two benefit as people worldwide are hesitant
Is Amwell Stock a Buy?
Investors (and people!) looking back on 2020 years from now will no doubt call it a year like no other in their lifetimes. The coronavirus pandemic has disrupted habits -- and perhaps helped form
3 Investing Moves to Make by the End of 2020
It's fair to say that 2020 has been a miserable year for many of us, so much so that at this point, a lot of people are probably ready to wish it away. But for better or worse, we only have about 11
3 Top Growth Stocks You Can Buy and Hold for the Next Decade
You need three things to buy and hold a stock for a decade: conviction, trust, and patience. You must be strongly convinced that the underlying company has solid growth catalysts for several years
Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics
Explosive growth potential. That's the big draw for the stocks of small biotechs with COVID-19 development programs. One successful coronavirus vaccine or therapy could translate to a lot of revenue
2 Stocks Robinhood Investors Will Regret Buying
Robinhood is a commission-free trading platform that is popular among millennials (the average age of a Robinhood user is 31). These investors, many of whom are newcomers to the investment world
3 Pandemic Stocks That Could Make You Rich
"Never let a good crisis go to waste."
When Winston Churchill made that memorable quip, World War II was the crisis he had in mind. But the sentiment is still applicable today in the midst of our


